These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13986245)

  • 1. [The influence of splenectomy on the antibody response and serum protein pattern in subjects with thalassemia major].
    PRIOLISI A; GIUFFRE L
    Pediatria (Napoli); 1962; 70():753-78. PubMed ID: 13986245
    [No Abstract]   [Full Text] [Related]  

  • 2. [INDICATIONS AND LIMITATIONS OF SPLENECTOMY IN THE TREATMENT OF THALASSEMIA MAJOR. CONSIDERATIONS ON 17 CASES].
    NICOLA P; D OLEGGIO AV; MOROSINI FIANDINO G
    Minerva Pediatr; 1963 Oct; 15():1047-56. PubMed ID: 14101059
    [No Abstract]   [Full Text] [Related]  

  • 3. Portal vein thrombosis after splenectomy for beta-thalassemia major.
    Al-Hawsawi ZM; Haouimi AS; Hassan RA; Tarawah AM
    Saudi Med J; 2004 Feb; 25(2):225-8. PubMed ID: 14968225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The features of immune status of major beta-thalassemia patients during various periods after splenectomy].
    Kadymova EA
    Georgian Med News; 2009 Sep; (174):39-44. PubMed ID: 19801729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gammaglobulinopoietic activity of the spleen and thalassemia major].
    Bardare M; Chiappino G
    Minerva Pediatr; 1967 Mar; 19(9):379-82. PubMed ID: 4179669
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
    Gharagozloo M; Karimi M; Amirghofran Z
    Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peculiarities of iron metabolism in patients with Beta - thalassemia at different periods after splenectomy].
    Kadimova E
    Georgian Med News; 2007 Nov; (152):35-7. PubMed ID: 18175831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic assessment of splenomegaly in beta-thalassemia patients undergoing splenectomy.
    Aessopos A; Farmakis D; Tsironi M; Deftereos S; Tassiopoulos S; Konstantopoulos K; Rombos J; Papalambros E
    Ann Hematol; 2004 Dec; 83(12):775-8. PubMed ID: 15338197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
    Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
    Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-3 and signaling pathways on beta-thalassemia/HbE erythroid progenitor cell in culture.
    Tanyong DI; Winichagoon P; Siripin D; Seevakool W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):897-903. PubMed ID: 18041309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
    Al-Quobaili FA; Abou Asali IE
    Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
    Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricuspid regurgitation in patients with beta-thalassemia major.
    Wu KH; Chang JS; Su BH; Peng CT
    Ann Hematol; 2004 Dec; 83(12):779-83. PubMed ID: 15449031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune system of splenectomized thalassemia patients in different periods after splenectomy].
    Kadimova E
    Georgian Med News; 2007 Oct; (151):47-52. PubMed ID: 18071213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
    Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
    Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation and activation in thalassemia major patients in Indonesia.
    Setiabudy R; Wahidiyat PA; Setiawan L
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant system activity in splenectomized versus non-splenectomized Iranian patients with beta-thalassemia major.
    Rashidi A; Alavi S; Arzanian MT; Ahmadinejad M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):645-7. PubMed ID: 18092257
    [No Abstract]   [Full Text] [Related]  

  • 19. [SPLENECTOMY IN THALASSEMIA MAJOR (APROPOS OF 2 CASES)].
    DELUCA G; MOLARO GL
    Minerva Pediatr; 1964 Nov; 16():1242-56. PubMed ID: 14228813
    [No Abstract]   [Full Text] [Related]  

  • 20. Common queries in thalassemia care.
    Panigrahi I; Marwaha RK
    Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.